SecBot SecBot
SECBOTREPLAY Home › Report › ABEO

ABEO · Kaufman 13G/A 7.3% stake

ABEONA THERAPEUTICS INC. · SC 13G/A filed Nov 12, 2026 at 13:02 ET

At the news

NEUTRALIMPACT 3/10

SC 13G/A filed Nov 12, 2026 at 13:02 ET

Daniel Kaufman filed an amended Schedule 13G disclosing a 7.3% passive stake in Abeona Therapeutics as of September 30, 2026. The filing is an amendment to a prior 13G, indicating Kaufman's stake increased from a previously undisclosed level. The passive nature and lack of activist intent make this a routine update.

  • Daniel Kaufman reported beneficial ownership of 4,159,099 shares of Abeona Therapeutics common stock as of September 30, 2026.
  • The stake represents 7.3% of shares outstanding.
  • The filing is an amendment to a prior Schedule 13G, indicating a change in position.
  • Kaufman certifies the shares were not acquired with the purpose of changing or influencing control of the issuer.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access